SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
Nguyen D. et al, (2025), J Virol
Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET.
Akıl C. et al, (2025), Nat Commun, 16
Docking for Smoothened antagonist chemotypes not susceptible to a vismodegib-resistance mutation.
Titulaer WHC. et al, (2025), Eur J Med Chem, 296
Structural maturation of the matrix lattice is not required for HIV-1 particle infectivity.
Chen L. et al, (2025), Sci Adv, 11
An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.
Zhang Y. et al, (2025), NPJ vaccines, 10
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Zwerwer LR. et al, (2025), Nature communications, 16
In-cell chromatin structure by Cryo-FIB and Cryo-ET.
Hou Z. and Zhang P., (2025), Current opinion in structural biology, 92
TSC2/mTORC1 integrates deoxynivalenol signals recognized by membrane receptors IR and EGFR to restrict intestinal stem cell function
Dou C-X. et al, (2025), Journal of Hazardous Materials, 138769 - 138769
Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.
Kim YC. et al, (2025), NPJ vaccines, 10
Bacterial pathogen deploys the iminosugar glycosyrin to manipulate plant glycobiology.
Sanguankiattichai N. et al, (2025), Science (New York, N.Y.), 388, 297 - 303
Molecular basis for the phosphorylation of bacterial tyrosine kinase Wzc.
Yang Y. et al, (2025), Nature communications, 16
Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitis.
Sun B. et al, (2025), Science advances, 11
Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts.
Mietzsch M. et al, (2025), Nature communications, 16
The E3 ubiquitin ligase MGRN1 targets melanocortin receptors MC1R and MC4R via interactions with transmembrane adapters.
Parashara P. et al, (2025), bioRxiv
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L. et al, (2025), NPJ vaccines, 10